| 2024-05-10 | Sale | Palantir Technologies Inc. PLTR | director | 5M 0.2368% | $20.78 | $103.92M | +6.46% | |
| 2024-05-09 | Sale | Palantir Technologies Inc. PLTR | director | 1.67M 0.0788% | $21.26 | $35.49M | +2.93% | |
| 2024-05-08 | Sale | Palantir Technologies Inc. PLTR | director | 6.29M 0.2919% | $21.33 | $134.08M | +0.86% | |
| 2024-03-12 | Sale | Palantir Technologies Inc. PLTR | director | 7.04M 0.3349% | $24.79 | $174.62M | -8.16% | |
| 2021-08-13 | Sale | Palantir Technologies Inc. PLTR | 3,262 0.0002% | $25.00 | $81,550 | -46.22% | ||
| 2021-03-16 | Chemomab Therapeutics Ltd. CMMB | 10 percent owner | 230,536 0.6772% | $17.35 | $4M | -83.55% | ||
| 2021-02-18 | Sale | Palantir Technologies Inc. PLTR | 40.01M 2.2024% | $25.23 | $1.01B | -8.32% | ||
| 2020-12-15 | AbCellera Biologics Inc. ABCL | director | 6M 1.6042% | $20.00 | $120M | -51.21% | ||
| 2020-10-02 | Sale | Palantir Technologies Inc. PLTR | 1,816 0.0001% | $9.14 | $16,598 | +161.3% | ||
| 2020-10-01 | Sale | Palantir Technologies Inc. PLTR | 8.74M 0.511% | $9.75 | $85.26M | +154.07% | ||
| 2020-09-30 | Sale | Palantir Technologies Inc. PLTR | 45.99M 2.8128% | $10.25 | $471.23M | +152.95% | ||
| 2020-02-06 | Sale | Meta Platforms, Inc. META | director | 53,602 0.0019% | $210.56 | $11.29M | +18.42% | |
| 2019-08-22 | Sale | Meta Platforms, Inc. META | director | 22,019 0.0008% | $181.98 | $4.01M | +10.84% |